Picture of Pharmena SA logo

PHR Pharmena SA Income Statement

0.000.00%
pl flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSuper Stock

Annual income statement for Pharmena SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
PAS
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue11.19.9315.20.2990.299
Cost of Revenue
Gross Profit7.45.087.830.091-0.001
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses21.415.919.24.35-32.6
Operating Profit-10.3-6.01-3.98-4.0532.9
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-10.7-6.27-4.46-4.9532.9
Provision for Income Taxes
Net Income After Taxes-9.57-6.96-4.64-5.1627
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-9.43-6.89-4.59-1.5728.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-9.43-6.89-4.59-1.5728.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.928-0.624-0.403-0.4542.44
Dividends per Share